Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

From Beginning To End, FDA Transparency Weighed On Sharfstein’s Mind

Executive Summary

As a lead player in FDA’s Transparency Initiative, outgoing Principal Deputy Commissioner Joshua Sharfstein helmed a task force that, on his penultimate day at the agency, unveiled a slew of measures to increase industry access to pertinent regulatory information.
Advertisement

Related Content

Roxane's Redesigned Morphine Carton Reflects Orderly Rollout After Safety Concern
FDA’s Unapproved Drugs Policy Draws Legal, Regulatory Responses From Lannett, To Little Success
FDA’s Unapproved Drugs Policy Draws Legal, Regulatory Responses From Lannett, To Little Success
FDA’s Congressional Relations, Internal Structure May Change With Sharfstein’s Departure
FDA’s Congressional Relations, Internal Structure May Change With Sharfstein’s Departure
Transparency Phase III: FDA Offers Designs For Industry Review
FDA’s Congressional Relations, Internal Structure May Change With Sharfstein’s Departure
FDA Transparency Initiative: Disclosure Rules Could Expand, Then Be Harmonized

Topics

Advertisement
UsernamePublicRestriction

Register

PS053008

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel